For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230904:nRSD1779La&default-theme=true
RNS Number : 1779L MyHealthChecked PLC 04 September 2023
MyHealthChecked PLC
("MyHealthChecked" or "the Company")
Notice of results
Investor presentation
MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company,
confirms that it will announce its interim results for the six months ended 30
June 2023 on Tuesday 19 September 2023.
Investor Briefing
Penny McCormick, Chief Executive Officer, will host a live online presentation
relating to the interim results via the Investor Meet Company platform
at 4.30pm on Tuesday 19 September 2023. The presentation is open to all
existing and potential shareholders.
Investors can sign up to Investor Meet Company for free and register for the
presentation here:
https://www.investormeetcompany.com/myhealthchecked -plc/register-investor
(https://www.investormeetcompany.com/myhealthchecked%20-plc/register-investor)
Investors who already follow MyHealthChecked on the Investor Meet Company
platform will be automatically invited.
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com (http://www.myhealthchecked.com)
Penny McCormick, Chief Executive Officer via Walbrook PR
SPARK Advisory Partners Limited (NOMAD) Tel: +44 (0)20 3368 3550
Neil Baldwin / Jade Bayat
Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media & IR) Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
(mailto:myhealthcheckedplc@walbrookpr.com)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654
About MyHealthChecked PLC (https://investors.myhealthchecked.com/
(https://investors.myhealthchecked.com/) )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK
healthcare company focused on a range of at-home healthcare and wellness
tests.
MyHealthChecked (http://www.myhealthchecked.com) is the umbrella brand of a
range of at-home rapid tests, as well as DNA, RNA and blood sample collection
kits which have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, whilst the sample collection
kits enable the collection of blood, urine, nasal or mouth swab samples that
are analysed in partner laboratories for a range of biomarkers. The tests will
also be made available online and will be viable for over-the-counter
purchase.
The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market with a focus on
accessibility at the right price, led by UK-based experts.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NORBUGDCRBGDGXB